The Munich Valsalva Implantation Technique (MuVIT) for Cardiac Output Reduction During TEVAR: Vena Cava Occlusion With the Valsalva Maneuver.


Journal

Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists
ISSN: 1545-1550
Titre abrégé: J Endovasc Ther
Pays: United States
ID NLM: 100896915

Informations de publication

Date de publication:
Feb 2021
Historique:
pubmed: 1 10 2020
medline: 21 5 2021
entrez: 30 9 2020
Statut: ppublish

Résumé

To demonstrate a physiologically induced alternative to the typical methods of reducing cardiac output during deployment of stent-grafts in the aortic arch and proximal aorta. A modified Valsalva maneuver, the Munich Valsalva implantation technique (MuVIT), to raise the intrathoracic pressure, minimize backflow, and reduce the cardiac output is illustrated in a patient undergoing a triple-branch thoracic endovascular aortic repair (TEVAR). During manual mechanical ventilation, the adjustable pressure-limiting valve is carefully closed to 25 mm Hg, creating "manual bloating" of the lungs and sustained apnea. The increased intrathoracic pressure causes compression of the vena cava and pulmonary veins, reducing the venous backflow and gradually decreasing the arterial pressure. Once the desired pressure is obtained, the stent-graft is accurately deployed. The airway pressure is thereupon slowly reduced, and the patient is taken back to normal ventilation. The procedure is then finished following standard practice. The MuVIT is a simple, noninvasive technique for cardiac output reduction during aortic arch TEVAR, eliminating the need for other invasive techniques.

Identifiants

pubmed: 32996398
doi: 10.1177/1526602820961376
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

7-13

Commentaires et corrections

Type : CommentIn

Auteurs

Nikolaos Tsilimparis (N)

Department of Vascular Surgery, University Hospital, LMU Munich, Munich, Germany.

Jan-Michel Abicht (JM)

Department of Anesthesiology, University Hospital, LMU Munich, Munich, Germany.

Jan Stana (J)

Department of Vascular Surgery, University Hospital, LMU Munich, Munich, Germany.

Nikolaos Konstantinou (N)

Department of Vascular Surgery, University Hospital, LMU Munich, Munich, Germany.

Barbara Rantner (B)

Department of Vascular Surgery, University Hospital, LMU Munich, Munich, Germany.

Ramin Banafsche (R)

Department of Vascular Surgery, University Hospital, LMU Munich, Munich, Germany.

Carlota Fernandez Prendes (C)

Department of Vascular Surgery, University Hospital, LMU Munich, Munich, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH